Hyperlipidemia 发表于 2025-3-25 06:03:06

http://reply.papertrans.cn/1/51/5082/5082-21.png

BRAWL 发表于 2025-3-25 07:35:34

Submitted on: 17 November 2006.
Revised on: 04 March 2007.
Accepted on: 19 April 2007.

___________________Chemical Biology & Drug Design

Spirometry 发表于 2025-3-25 13:24:29

Submitted on: 13 September 2010.
Revised on: 01 November 2010.
Accepted on: 17 December 2010.

___________________Chemical Biology & Drug Design

开始没有 发表于 2025-3-25 19:17:51

http://reply.papertrans.cn/1/51/5082/5082-24.png

lymphedema 发表于 2025-3-25 22:12:49

Submitted on: 05 June 1998.
Revised on: 19 August 1998.
Accepted on: 27 September 1998.

___________________Chemical Biology & Drug Design

habitat 发表于 2025-3-26 02:18:56

Submitted on: 17 June 2000.
Revised on: 10 July 2000.
Accepted on: 21 July 2000.

___________________Chemical Biology & Drug Design

Deduct 发表于 2025-3-26 07:54:03

Submitted on: 09 July 2003.
Revised on: 29 October 2003.
Accepted on: 14 November 2003.

___________________Chemical Biology & Drug Design

Expiration 发表于 2025-3-26 10:04:37

Submitted on: 20 January 2019.
Revised on: 10 March 2019.
Accepted on: 03 May 2019.

___________________Chemical Biology & Drug Design

Anthem 发表于 2025-3-26 14:46:45

Submitted on: 24 March 2001.
Revised on: 12 June 2001.
Accepted on: 05 July 2001.

___________________Chemical Biology & Drug Design

intertwine 发表于 2025-3-26 18:17:14

http://reply.papertrans.cn/1/51/5082/5082-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊Chemical Biology & Drug Design 2024/2025影响因子:3.289 (CHEM BIOL DRUG DES) (1747-0277). (BIOCHEMISTRY & MOLECULAR BI